Detalles de la búsqueda
1.
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Lancet
; 402(10401): 555-570, 2023 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423231
2.
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
Catheter Cardiovasc Interv
; 95(5): 885-892, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31197962
3.
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Catheter Cardiovasc Interv
; 93(3): E112-E119, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30351514
4.
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Catheter Cardiovasc Interv
; 94(1): 53-60, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656812
5.
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.
J Thromb Thrombolysis
; 48(1): 42-51, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924052
6.
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
Am Heart J
; 188: 73-81, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577683
7.
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
Catheter Cardiovasc Interv
; 89(4): 629-637, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27152497
8.
A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritis.
CPT Pharmacometrics Syst Pharmacol
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532270
9.
Microsampling in pediatric studies: pharmacokinetic sampling for baricitinib (Olumiant™) in global pediatric studies.
Bioanalysis
; 15(11): 621-636, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37293791
10.
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study.
Eur Heart J Acute Cardiovasc Care
; 12(9): 594-603, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37459570
11.
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
Trials
; 22(1): 689, 2021 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34627340
12.
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study.
Clin Res Cardiol
; 109(6): 725-734, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31915997
13.
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention.
Int J Cardiol
; 275: 31-35, 2019 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30391067
14.
One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.
Am J Cardiovasc Drugs
; 18(2): 129-141, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29222628
15.
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.
Can J Cardiol
; 34(3): 319-329, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29475531
16.
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
JACC Cardiovasc Interv
; 10(20): 2017-2025, 2017 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28780028
17.
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel.
Am J Cardiovasc Drugs
; 15(5): 337-50, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26359016
Resultados
1 -
17
de 17
1
Próxima >
>>